WaVE Lifes Sciences pulls in $18 mln
Boston and Japan-based WaVe Life Sciences, a provider of nucleic acid therapeutics, has raised $18 million in Series A funding. RA Capital Management LLC and Kagoshima Shinsangyo Sosei Investment LP led the round with participation from founding investor SNBL Ltd. In addition to the financing, Dr. Peter Kolchinsky, a managing general partner of RA Capital, has been added to WaVe’s board of directors.
2 February 2015•3 mins read
